AI
Anthropic Demands ID, Selfies From Claude Users
Anthropic starts scanning government IDs on July 8. Consumers face biometric checks, but the API exemption reveals the real dividing line.
Latest — Page 5
FDA
Failed: Exelixis' Zanzalintinib NLM Endpoint; Dec. 3 PDUFA
Exelixis' zanzalintinib missed OS in the NLM subgroup, putting roughly half of a $1.3B peak-sales estimate at stake before the Dec. 3 FDA call.
FDA
Definium DT120 Clears Phase 3 MDD; Stock +50%
LSD-based DT120 beat placebo by 8.1 MADRS points and held the gain through week 12. Definium's FDA submission just got a lot more credible.
Legal
OCC Brings Stablecoin Issuers Under Bank Secrecy Act
OCC's Bank Secrecy Act rule for stablecoin issuers arrived the same week five agencies jointly proposed mandatory KYC for the same companies.
Legal
Davenport Filed $20K Junk-Fee Map, States on Notice
With the CFPB retreating, NJ AG Davenport's $20K-per-violation junk-fee blueprint may hand every state AG a ready-made enforcement map.
Deals
Nuvectis Buys Haisco Factor B Rights for $40M
Nuvectis paid $40M upfront for ex-China rights to Haisco's once-daily Factor B inhibitor in a PNH market projected above $5B in 2026.
Legal
Polymarket Faked $900K in Wins to Lure US Users
Polymarket staged $900K in fake wins for banned US users using copycat sites and a hired creator network. Its second marketing scandal in three weeks.
Deals
Insilico Bags $2.5B SK Deal, $18M Upfront and Near-Term
SK Biopharmaceuticals is putting $18M upfront on a $2.5B Insilico neuroimmune deal — and the backloaded structure tells you who blinked.
Legal
4 State AGs Probe FIFA World Cup Ticket Practices
Four state AGs are probing FIFA's World Cup tickets: seat bait-and-switch, sky-high variable pricing, and no consumer disclosure framework.
AI
Backdoored: North Korea Hits 140 Mastra npm Packages
Sapphire Sleet compromised a single dormant npm account and poisoned 140 Mastra AI packages in 88 minutes. The malware ran on install, not import.
Deals
Hits $2B Revenue, Kalshi Eyes IPO
Kalshi hit $2B in annualized revenue, doubled its valuation in five months, and is now talking to banks about an IPO it won't need until 2027.
Deals
Memento Raises $93M, Buys VEGF-Tie2 Eye Bispecific
Memento raised $93M and licensed a VEGF-Tie2 bispecific for nAMD and DME, conditions driving $4.4B in U.S. Eylea franchise sales last year.
AI
UK Pays $400K for AI That Calls 13-Year-Olds Adults
The UK spent $400K on face-scanning AI it knows misidentifies 13-year-old girls as adults, and still plans to deploy it on asylum seekers by 2027.
Legal
USTR Files Section 301 Against Germany Drug Pricing
USTR just filed Section 301 against Germany's €16B drug cost-cut plan. The UK deal is the blueprint, and a Sept. 22 hearing is now on the calendar.
Legal
Leaked: EU Commission Banking Draft Eyes Basel III Relief
EU Commission's leaked banking draft proposes Basel III relief for smaller lenders and capital relief on mortgages, but falls short of banks' ask.
